Abstract
EGFR, ALK and MET exon 14 skip are prevalent lung cancer drivers in Brazil, but detection by NGS is not feasible in 1/3 of the cases.
Cite
CITATION STYLE
APA
Dienstmann, R., da Silva, L. M., Orpinelli Ramos do Rego, F., Muniz Rodrigues, A., Koyama, F. C., Galindo, L. T., … Ferreira, C. G. (2024). Real-World Study on Implementation of Genomic Tests for Advanced Lung Adenocarcinoma in Brazil. JCO Global Oncology, (10). https://doi.org/10.1200/go-24-00354
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free